Tiger_老虎社区_美港股上老虎

vikkyngau
2021-06-23

Tiger

China stocks gain as country approves first CAR-T cell therapy

* SSEC +0.46%, CSI300 +0.77%, HSI +1.46% * Powell reiterates inflation stability * China approves fi

China stocks gain as country approves first CAR-T cell therapy

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":123538068,"tweetId":"123538068","gmtCreate":1624428604754,"gmtModify":1634006236105,"author":{"id":3585359254677948,"idStr":"3585359254677948","authorId":3585359254677948,"authorIdStr":"3585359254677948","name":"vikkyngau","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Tiger&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Tiger&nbsp;</p></body></html>","text":"Tiger","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/123538068","repostId":2145406056,"repostType":4,"repost":{"id":"2145406056","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624425821,"share":"https://ttm.financial/m/news/2145406056?lang=&edition=full","pubTime":"2021-06-23 13:23","market":"hk","language":"en","title":"China stocks gain as country approves first CAR-T cell therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2145406056","media":"Reuters","summary":"* SSEC +0.46%, CSI300 +0.77%, HSI +1.46%\n* Powell reiterates inflation stability\n* China approves fi","content":"<p>* SSEC +0.46%, CSI300 +0.77%, HSI +1.46%</p>\n<p>* Powell reiterates inflation stability</p>\n<p>* China approves first CAR-T cell therapy</p>\n<p>* Healthcare sub-index climbs over 1%</p>\n<p>SHANGHAI, June 23 (Reuters) - China shares rose on Wednesday, with healthcare stocks leading the gains after the country approved its first CAR-T cell therapy, while investors cheered the Federal Reserve's assurance that the U.S. central bank will not hasten to hike rates.</p>\n<p>** At the midday break, the Shanghai Composite index was up 0.46% at 3,573.61 points, rising for the third consecutive day. China's blue-chip CSI300 index was up 0.77%.</p>\n<p>** The financial sector sub-index climbed 0.13%, the consumer staples sector was down 1.24%, while the real estate index added 0.13%.</p>\n<p>** Chinese H-shares listed in Hong Kong rose 1.43% to 10,619.02, while the Hang Seng Index was up 1.46% at 28,721.85.</p>\n<p>** The smaller Shenzhen index was up 0.81%, the start-up board ChiNext Composite index advanced 1.63%, and Shanghai's tech-focused STAR50 index climbed 1.53%.</p>\n<p>** The largest percentage gainers in the main Shanghai Composite index were Liaoning SG Automotive Group Co Ltd , up 10.1%, followed by Anhui Jianghuai Automobile Group Corp Ltd, gaining 10.05%.</p>\n<p>** Shanghai-listed shares of <a href=\"https://laohu8.com/S/SFOSF\">Shanghai Fosun Pharmaceutical Group Co Ltd</a> rose as much as 3.4% after China approved the first CAR-T cell therapy in the country as a joint venture of Fosun Pharmaceutical had obtained the rights to sell the therapy in China.</p>\n<p>** Leading the gains, the healthcare sub-index rose 1.11%.</p>\n<p>** Lifting investors' risk appetite was Fed chief Jerome Powell's reassurance of the goal of a broad labour market recovery while he also said fear of inflation alone would not be enough to prompt rate rises.</p>\n<p>** China's state planner said on Wednesday that it and the market regulator have recently sent teams to various areas to look into commodities prices and supplies and would learn about mid- and downstream companies' situations.</p>\n<p>** Around the region, MSCI's Asia ex-Japan stock index&nbsp;was firmer by 0.74% while Japan's Nikkei index&nbsp;was up 0.02%.</p>\n<p>** The yuan was quoted at 6.4807 per U.S. dollar, 0% firmer than the previous close of 6.481.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China stocks gain as country approves first CAR-T cell therapy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina stocks gain as country approves first CAR-T cell therapy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-23 13:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* SSEC +0.46%, CSI300 +0.77%, HSI +1.46%</p>\n<p>* Powell reiterates inflation stability</p>\n<p>* China approves first CAR-T cell therapy</p>\n<p>* Healthcare sub-index climbs over 1%</p>\n<p>SHANGHAI, June 23 (Reuters) - China shares rose on Wednesday, with healthcare stocks leading the gains after the country approved its first CAR-T cell therapy, while investors cheered the Federal Reserve's assurance that the U.S. central bank will not hasten to hike rates.</p>\n<p>** At the midday break, the Shanghai Composite index was up 0.46% at 3,573.61 points, rising for the third consecutive day. China's blue-chip CSI300 index was up 0.77%.</p>\n<p>** The financial sector sub-index climbed 0.13%, the consumer staples sector was down 1.24%, while the real estate index added 0.13%.</p>\n<p>** Chinese H-shares listed in Hong Kong rose 1.43% to 10,619.02, while the Hang Seng Index was up 1.46% at 28,721.85.</p>\n<p>** The smaller Shenzhen index was up 0.81%, the start-up board ChiNext Composite index advanced 1.63%, and Shanghai's tech-focused STAR50 index climbed 1.53%.</p>\n<p>** The largest percentage gainers in the main Shanghai Composite index were Liaoning SG Automotive Group Co Ltd , up 10.1%, followed by Anhui Jianghuai Automobile Group Corp Ltd, gaining 10.05%.</p>\n<p>** Shanghai-listed shares of <a href=\"https://laohu8.com/S/SFOSF\">Shanghai Fosun Pharmaceutical Group Co Ltd</a> rose as much as 3.4% after China approved the first CAR-T cell therapy in the country as a joint venture of Fosun Pharmaceutical had obtained the rights to sell the therapy in China.</p>\n<p>** Leading the gains, the healthcare sub-index rose 1.11%.</p>\n<p>** Lifting investors' risk appetite was Fed chief Jerome Powell's reassurance of the goal of a broad labour market recovery while he also said fear of inflation alone would not be enough to prompt rate rises.</p>\n<p>** China's state planner said on Wednesday that it and the market regulator have recently sent teams to various areas to look into commodities prices and supplies and would learn about mid- and downstream companies' situations.</p>\n<p>** Around the region, MSCI's Asia ex-Japan stock index&nbsp;was firmer by 0.74% while Japan's Nikkei index&nbsp;was up 0.02%.</p>\n<p>** The yuan was quoted at 6.4807 per U.S. dollar, 0% firmer than the previous close of 6.481.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145406056","content_text":"* SSEC +0.46%, CSI300 +0.77%, HSI +1.46%\n* Powell reiterates inflation stability\n* China approves first CAR-T cell therapy\n* Healthcare sub-index climbs over 1%\nSHANGHAI, June 23 (Reuters) - China shares rose on Wednesday, with healthcare stocks leading the gains after the country approved its first CAR-T cell therapy, while investors cheered the Federal Reserve's assurance that the U.S. central bank will not hasten to hike rates.\n** At the midday break, the Shanghai Composite index was up 0.46% at 3,573.61 points, rising for the third consecutive day. China's blue-chip CSI300 index was up 0.77%.\n** The financial sector sub-index climbed 0.13%, the consumer staples sector was down 1.24%, while the real estate index added 0.13%.\n** Chinese H-shares listed in Hong Kong rose 1.43% to 10,619.02, while the Hang Seng Index was up 1.46% at 28,721.85.\n** The smaller Shenzhen index was up 0.81%, the start-up board ChiNext Composite index advanced 1.63%, and Shanghai's tech-focused STAR50 index climbed 1.53%.\n** The largest percentage gainers in the main Shanghai Composite index were Liaoning SG Automotive Group Co Ltd , up 10.1%, followed by Anhui Jianghuai Automobile Group Corp Ltd, gaining 10.05%.\n** Shanghai-listed shares of Shanghai Fosun Pharmaceutical Group Co Ltd rose as much as 3.4% after China approved the first CAR-T cell therapy in the country as a joint venture of Fosun Pharmaceutical had obtained the rights to sell the therapy in China.\n** Leading the gains, the healthcare sub-index rose 1.11%.\n** Lifting investors' risk appetite was Fed chief Jerome Powell's reassurance of the goal of a broad labour market recovery while he also said fear of inflation alone would not be enough to prompt rate rises.\n** China's state planner said on Wednesday that it and the market regulator have recently sent teams to various areas to look into commodities prices and supplies and would learn about mid- and downstream companies' situations.\n** Around the region, MSCI's Asia ex-Japan stock index was firmer by 0.74% while Japan's Nikkei index was up 0.02%.\n** The yuan was quoted at 6.4807 per U.S. dollar, 0% firmer than the previous close of 6.481.","news_type":1,"symbols_score_info":{"000001.SH":0.9}},"isVote":1,"tweetType":1,"viewCount":848,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}